Fiche de révision : Endocrine Disorders: Thyroid, Diabetes, Adrenal, Pituitary

📋 Course Outline

1. Thyroid-stimulating hormone
2. Thyroid hormone synthesis
3. Autoimmune thyroiditis markers
4. Hyperthyroidism treatment
5. Thyroid cancer diagnostics
6. Diabetes mellitus diagnosis
7. Insulin therapy principles
8. Diabetic complications
9. Adrenal gland disorders
10. Pituitary and hypothalamic diseases

📖 1. Thyroid-stimulating hormone

🔑 Key Concepts & Definitions

• Thyroid-stimulating hormone (TSH): A hormone produced by the anterior pituitary gland that stimulates the thyroid gland to produce thyroid hormones (T3 and T4).
• Hypothalamic-pituitary-thyroid axis: The regulatory system involving the hypothalamus, pituitary gland, and thyroid gland, controlling thyroid hormone levels via feedback mechanisms.
• Trophic hormone: A hormone that promotes growth and function of its target gland, in this case, TSH stimulates thyroid gland growth and hormone synthesis.
• Feedback regulation: The process where thyroid hormones (T3 and T4) inhibit TSH secretion to maintain hormonal balance.
• Autoimmune thyroiditis: An autoimmune disorder often associated with elevated TSH levels due to destruction of thyroid tissue, leading to hypothyroidism.
• TSH secretion regulation: Controlled primarily by thyrotropin-releasing hormone (TRH) from the hypothalamus and feedback from circulating thyroid hormones.

📝 Essential Points

• TSH is secreted by the anterior pituitary in response to TRH from the hypothalamus.
• Elevated TSH levels typically indicate hypothyroidism, while low levels suggest hyperthyroidism.
• TSH levels are used diagnostically to evaluate thyroid function and distinguish between primary (thyroid gland) and secondary (pituitary or hypothalamic) disorders.
• TSH secretion is suppressed by high levels of circulating T3 and T4 (negative feedback).
• In autoimmune thyroid diseases, TSH levels help determine disease activity and guide treatment.
• TSH testing is crucial in screening for thyroid dysfunction, especially in pregnancy and neonatal screening.

💡 Key Takeaway

Thyroid-stimulating hormone is a vital regulator of thyroid function, with its levels reflecting the balance between the hypothalamus, pituitary, and thyroid gland, making it essential for diagnosing and managing thyroid disorders.

📖 2. Thyroid hormone synthesis

🔑 Key Concepts & Definitions

• Thyroid Hormones (T3 and T4): Active hormones produced by the thyroid gland, responsible for regulating metabolism, growth, and development. T3 (triiodothyronine) is more potent, while T4 (thyroxine) is the main circulating form that is converted into T3 in tissues.

• Iodide Trapping: The process by which thyroid follicular cells actively transport iodide from the bloodstream into the thyroid gland, essential for hormone synthesis.

• Thyroglobulin: A large glycoprotein synthesized by follicular cells, serving as a precursor for thyroid hormones. Iodination of tyrosine residues within thyroglobulin leads to hormone formation.

• Organification of Iodide: The process where iodide is oxidized and attached to tyrosine residues in thyroglobulin, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT).

• Coupling Reaction: The chemical process where MIT and DIT combine within thyroglobulin to form T3 and T4 hormones.

• Hormone Release: The step where thyroglobulin containing T3 and T4 is endocytosed, degraded, and hormones are released into circulation.

📝 Essential Points

• Iodide Uptake: Initiated by the sodium-iodide symporter (NIS) located on follicular cells, driven by sodium gradient maintained by Na+/K+ ATPase.

• Oxidation of Iodide: Catalyzed by thyroid peroxidase (TPO), converting iodide to iodine, which then iodinates tyrosine residues on thyroglobulin.

• Hormone Synthesis: Involves iodination (organification) and coupling within the colloid of the follicle, producing MIT and DIT, which are precursors to T3 and T4.

• Hormone Release: Triggered by TSH (thyroid-stimulating hormone), leading to endocytosis of thyroglobulin, proteolysis, and release of T3 and T4 into blood.

• Regulation: TSH from the pituitary gland regulates all steps, including iodide trapping, hormone synthesis, and secretion.

• Iodine Deficiency: Leads to decreased hormone synthesis, resulting in goiter and hypothyroidism.

💡 Key Takeaway

Thyroid hormone synthesis is a complex, tightly regulated process involving iodide trapping, organification, coupling within thyroglobulin, and hormone release, primarily controlled by TSH. Proper functioning of each step is essential for maintaining metabolic homeostasis.

📖 3. Autoimmune thyroiditis markers

🔑 Key Concepts & Definitions

• Thyroid-Stimulating Hormone (TSH): Hormone produced by the pituitary gland that stimulates the thyroid gland to produce thyroid hormones (T4 and T3). Elevated TSH indicates hypothyroidism, while suppressed TSH suggests hyperthyroidism.
• Free Thyroxine (Free T4): The unbound, biologically active form of T4 in the blood. Decreased levels are typical in hypothyroidism; increased in hyperthyroidism.
• Anti-Thyroid Peroxidase Antibodies (AT TPO): Autoantibodies directed against thyroid peroxidase enzyme, a key component in thyroid hormone synthesis. Presence indicates autoimmune thyroiditis.
• Goiter: Enlargement of the thyroid gland, often associated with autoimmune thyroiditis, especially when accompanied by antibody positivity.
• Thyroid Autoantibodies: Include anti-TPO and anti-thyroglobulin antibodies; markers of autoimmune destruction of thyroid tissue.
• Thyroid Ultrasound: Imaging modality to assess gland size, echogenicity, and presence of nodules, often showing increased size and heterogeneity in autoimmune thyroiditis.

📝 Essential Points

• Markers of Autoimmune Thyroiditis: Elevated anti-TPO antibodies and anti-thyroglobulin antibodies are primary serological markers.
• Thyroid Function Tests: Elevated TSH with decreased free T4 suggests hypothyroidism, common in autoimmune thyroiditis (Hashimoto's).
• Thyroid Gland Changes: Enlargement (goiter) and heterogeneity on ultrasound support diagnosis.
• Correlation: Presence of autoantibodies correlates with gland destruction and hypothyroidism; their titers can fluctuate with disease activity.
• Diagnostic Approach: Combines clinical features, antibody testing, TSH, free T4 levels, and ultrasound findings.
• Other Markers: Elevated levels of thyroglobulin antibodies may also be present but are less specific.

💡 Key Takeaway

Autoimmune thyroiditis is characterized by elevated anti-TPO antibodies, abnormal thyroid function tests (high TSH, low free T4), and gland changes on ultrasound, serving as key markers for diagnosis and disease activity assessment.

📖 4. Hyperthyroidism treatment

🔑 Key Concepts & Definitions

• Hyperthyroidism: A condition characterized by excessive production of thyroid hormones (T3 and T4), leading to increased metabolic activity.
• Thyroidectomy: Surgical removal of part or all of the thyroid gland, used as a treatment option for hyperthyroidism.
• Radioactive Iodine Therapy (RAI): A treatment involving oral administration of radioactive iodine (I-131) to destroy overactive thyroid tissue.
• Antithyroid Drugs (Thionamides): Medications such as methimazole and propylthiouracil that inhibit thyroid hormone synthesis.
• Beta-Blockers: Medications like propranolol used to control symptoms such as tachycardia, tremors, and anxiety in hyperthyroid patients.
• Thyroid Storm: A life-threatening exacerbation of hyperthyroidism requiring urgent treatment, including supportive care and antithyroid medications.

📝 Essential Points

• First-line treatment: Antithyroid drugs (methimazole preferred over propylthiouracil due to fewer side effects) are typically used initially.
• Radioactive iodine therapy: Commonly used for adults; causes gradual destruction of thyroid tissue, often leading to hypothyroidism.
• Surgical intervention: Thyroidectomy is indicated in cases of large goiters, suspicion of malignancy, or failure of medical therapy.
• Symptom control: Beta-blockers are used temporarily to manage adrenergic symptoms until definitive treatment takes effect.
• Monitoring: Regular assessment of thyroid function tests (T3, T4, TSH) is essential to guide therapy adjustments.
• Complications: Over-treatment can cause hypothyroidism; under-treatment may lead to persistent hyperthyroidism or thyroid storm.

💡 Key Takeaway

Effective management of hyperthyroidism involves a combination of medications, radioactive iodine, or surgery, tailored to the patient's condition, with careful monitoring to prevent complications and achieve euthyroidism.

📖 5. Thyroid cancer diagnostics

🔑 Key Concepts & Definitions

• Thyroid nodules: Discrete lumps within the thyroid gland, which can be benign or malignant; initial detection often via palpation or imaging.
• Ultrasound (US) features: Imaging characteristics used to assess nodule malignancy risk, including hypoechogenicity, irregular margins, microcalcifications, taller-than-wide shape, and increased vascularity.
• Fine-needle aspiration biopsy (FNAB): Minimally invasive procedure to extract cells from a thyroid nodule for cytological examination, crucial for diagnosis.
• Thyroid scintigraphy: Nuclear imaging using radioactive isotopes (e.g., iodine-123) to evaluate nodule function; "hot" nodules are usually benign, "cold" nodules require further assessment.
• Serum thyroglobulin (Tg): Protein produced by thyroid tissue; used as a tumor marker in differentiated thyroid cancers, especially post-treatment.
• Molecular testing: Genetic analysis of FNAB samples for mutations (e.g., BRAF, RAS) to refine malignancy risk assessment.

📝 Essential Points

• Initial assessment: Palpation and ultrasound are primary tools for detecting and characterizing thyroid nodules.
• Ultrasound risk stratification: Features such as microcalcifications, irregular margins, and taller-than-wide shape increase suspicion of malignancy.
• FNAB indications: Recommended for nodules >1 cm with suspicious ultrasound features or >1.5-2 cm if less suspicious; helps confirm diagnosis.
• Cytology categories: Bethesda System classifies FNAB results into six categories, guiding management decisions.
• Molecular markers: Enhance diagnostic accuracy, especially in indeterminate cytology, influencing surgical planning.
• Additional tests: Serum Tg and calcitonin levels assist in diagnosis and follow-up, especially for medullary thyroid carcinoma.

💡 Key Takeaway

Thyroid cancer diagnosis relies on a combination of ultrasound features, cytological examination via FNAB, and molecular testing, enabling accurate differentiation between benign and malignant nodules for appropriate management.

📖 6. Diabetes mellitus diagnosis

🔑 Key Concepts & Definitions

• Fasting Blood Glucose (FBG): The concentration of glucose in venous blood after an overnight fast (at least 8 hours).
  Diagnostic threshold: ≥ 7.0 mmol/L indicates diabetes.

• Oral Glucose Tolerance Test (OGTT): A test measuring blood glucose 2 hours after ingesting 75g of glucose.
  Diagnostic threshold: ≥ 11.1 mmol/L indicates diabetes.

• Glycated Hemoglobin (HbA1c): A measure of average blood glucose over the past 2-3 months, reflecting glycemic control.
  Diagnostic threshold: ≥ 6.5% indicates diabetes.

• Impaired Fasting Glucose (IFG): FBG levels between 5.6 and 6.9 mmol/L, indicating prediabetes.
  Note: Not diagnostic of diabetes but indicates increased risk.

• Impaired Glucose Tolerance (IGT): 2-hour plasma glucose between 7.8 and 11.0 mmol/L during OGTT, indicating prediabetes.

• Glycemic Criteria for Diagnosis:

  • FBG ≥ 7.0 mmol/L
  • 2-hour OGTT ≥ 11.1 mmol/L
  • HbA1c ≥ 6.5%
  • Random plasma glucose ≥ 11.1 mmol/L with symptoms

📝 Essential Points

• The diagnostic methods include fasting blood glucose, OGTT, and HbA1c, with specific thresholds for each.
• OGTT is particularly useful for detecting impaired glucose tolerance, especially in high-risk groups.
• HbA1c provides a convenient, less variable measure of long-term glycemic control, but can be affected by hemoglobinopathies and anemia.
• Confirmatory testing is recommended if initial results are borderline or inconsistent.
• The maximum normal fasting glucose in healthy individuals is generally below 6.1 mmol/L; levels above suggest hyperglycemia.
• Post-load glucose levels are critical for diagnosing diabetes, with 2-hour values ≥ 11.1 mmol/L confirming diagnosis.

💡 Key Takeaway

Diabetes mellitus diagnosis relies on specific blood glucose and HbA1c thresholds, with multiple tests used to confirm the condition, enabling early intervention and management.

📖 7. Insulin therapy principles

🔑 Key Concepts & Definitions

• Insulin Resistance: A condition where body tissues (muscle, fat, liver) have a diminished response to insulin, leading to increased insulin requirements and hyperglycemia.
• Insulin Dose: The amount of insulin administered, often exceeding 20 units per day in cases of significant resistance or high needs.
• Hypoglycemia: A dangerous drop in blood glucose levels, often caused by excessive insulin or mismatched carbohydrate intake.
• Insulin Lipodystrophy: Local tissue changes (atrophy or hypertrophy) at injection sites, which can be prevented by rotating injection sites.
• Metabolic Syndrome: A cluster of conditions including abdominal obesity, dyslipidemia, hypertension, and insulin resistance, increasing cardiovascular risk.
• "Honeymoon" Phase: A temporary period in Type 1 diabetes where endogenous insulin production partially recovers, reducing exogenous insulin needs.

📝 Essential Points

• Insulin therapy is indicated when oral hypoglycemics are insufficient, especially with high insulin requirements (>20 units/day).
• Insulin resistance can be managed through increased doses, use of metformin, physical activity, and weight reduction.
• Clinical signs of insulin resistance include increased waist circumference (>80 cm women, >94 cm men), acanthosis nigricans, and abdominal obesity.
• To prevent hypoglycemia during short physical activity (<1 hour), consume 1-2 units of easily digestible carbohydrates beforehand and adjust insulin doses accordingly.
• The effectiveness of insulin may be reduced by antibodies, pancreatic pathology, or long duration of diabetes.
• Proper injection site rotation is essential to prevent lipodystrophy.
• Insulin therapy is crucial in Type 2 diabetes with significant hyperglycemia, resistance to oral agents, or during pregnancy.
• Side effects include weight gain, hypoglycemia, and potential injection site reactions.
• The "honeymoon" phase in Type 1 diabetes involves a significant reduction in insulin needs, sometimes allowing temporary discontinuation.

💡 Key Takeaway

Effective insulin therapy requires understanding resistance mechanisms, proper dosing, and management of side effects to achieve optimal glycemic control and prevent complications.

📖 8. Diabetic complications

🔑 Key Concepts & Definitions

• Diabetic Nephropathy: Kidney damage caused by long-term diabetes, characterized by microalbuminuria progressing to proteinuria and renal failure.
• Diabetic Retinopathy: Damage to retinal blood vessels due to hyperglycemia, leading to vision impairment or blindness.
• Diabetic Neuropathy: Nerve damage resulting from chronic high blood sugar, affecting sensory, motor, and autonomic nerves.
• Macroangiopathy: Large vessel disease in diabetics, including coronary artery disease, cerebrovascular disease, and peripheral arterial disease.
• Microangiopathy: Small vessel disease affecting capillaries and arterioles, leading to complications like retinopathy, nephropathy, and neuropathy.
• Glycemic Control: Management of blood glucose levels to prevent or delay diabetic complications; often monitored via HbA1c levels.

📝 Essential Points

• Chronic hyperglycemia damages blood vessels and nerves, leading to both microvascular and macrovascular complications.
• Early detection through screening (e.g., microalbuminuria, retinal exams) is crucial for preventing progression.
• Tight glycemic control reduces the risk and severity of diabetic microvascular complications.
• Hypertension and dyslipidemia significantly increase the risk of macrovascular complications.
• Management includes blood glucose regulation, blood pressure control, lipid management, and lifestyle modifications.
• Late complications include blindness, renal failure, amputations, and cardiovascular events.

💡 Key Takeaway

Effective management of blood glucose, blood pressure, and lipids is essential to prevent or delay the development of diabetic complications, which are major causes of morbidity and mortality in diabetic patients.

📖 9. Adrenal gland disorders

🔑 Key Concepts & Definitions

• Addison's Disease: Primary adrenal insufficiency caused by destruction or dysfunction of the adrenal cortex, leading to decreased production of cortisol, aldosterone, and androgens. Symptoms include fatigue, hypotension, hyperpigmentation, and electrolyte imbalances.

• Cushing's Syndrome: A condition resulting from excess cortisol levels, either due to endogenous overproduction (e.g., adrenal tumors, pituitary adenomas) or exogenous corticosteroid use. Manifestations include obesity, hypertension, glucose intolerance, and skin changes.

• Adrenal Crisis: Acute, life-threatening state caused by severe adrenal insufficiency, often triggered by stress or abrupt withdrawal of corticosteroids, characterized by hypotension, dehydration, hypoglycemia, and electrolyte disturbances.

• Primary vs. Secondary Adrenal Insufficiency: Primary involves direct adrenal gland failure (e.g., Addison's), while secondary results from pituitary or hypothalamic dysfunction leading to decreased ACTH secretion.

• Pheochromocytoma: A catecholamine-secreting tumor of the adrenal medulla, causing episodic hypertension, headaches, sweating, and tachycardia.

• Adrenal Tumors: Can be benign or malignant; functional tumors secrete hormones like cortisol, aldosterone, or catecholamines, affecting systemic physiology.

📝 Essential Points

• Diagnosis of Adrenal Disorders: Involves hormonal assays (cortisol, ACTH, aldosterone, catecholamines), imaging (CT, MRI), and dynamic tests (ACTH stimulation test, dexamethasone suppression test).

• Addison's Disease: Confirmed by low cortisol levels, high ACTH, and often hyperpigmentation; requires lifelong hormone replacement therapy.

• Cushing's Syndrome: Diagnosed via elevated cortisol levels, abnormal dexamethasone suppression tests, and imaging to identify the source.

• Adrenal Crisis Management: Immediate IV hydrocortisone, correction of hypoglycemia, electrolytes, and fluid replacement.

• Treatment Approaches: Hormone replacement (hydrocortisone, fludrocortisone), surgical removal of tumors, and management of complications.

• Complications: Include electrolyte disturbances, cardiovascular instability, osteoporosis, and increased susceptibility to infections.

💡 Key Takeaway

Adrenal gland disorders encompass a spectrum of conditions involving hormone excess or deficiency; accurate diagnosis and prompt treatment are vital to prevent life-threatening complications and restore hormonal balance.

📖 10. Pituitary and hypothalamic diseases

🔑 Key Concepts & Definitions

• Hypothalamic Disease: Disorders caused by damage or dysfunction of the hypothalamus, affecting hormone regulation and secretion, leading to conditions such as hypothalamic hypogonadism or hypothalamic obesity.

• Pituitary Adenoma: A benign tumor of the pituitary gland that can produce excess hormones (functional) or cause mass effects (non-functional), leading to syndromes like acromegaly or Cushing's disease.

• Hypopituitarism: Deficiency of one or more pituitary hormones due to gland destruction, tumor, or ischemia, resulting in various endocrine deficiencies such as hypothyroidism, adrenal insufficiency, or hypogonadism.

• Syndrome of Inappropriate Antidiuretic Hormone (SIADH): Excess secretion of ADH from the posterior pituitary or ectopic sources, causing water retention, hyponatremia, and concentrated urine.

• Empty Sella Syndrome: Condition where the sella turcica appears empty on imaging due to herniation of the subarachnoid space or loss of pituitary tissue, often asymptomatic but may cause hormonal deficiencies.

• Craniopharyngioma: A benign, cystic tumor near the pituitary gland that can cause hormonal disturbances and visual disturbances due to mass effect.

📝 Essential Points

• Hormonal Regulation: The hypothalamus controls the pituitary gland via releasing and inhibiting hormones; damage to either can disrupt endocrine balance.

• Clinical Manifestations: Depend on the specific hormones affected; may include growth failure, menstrual irregularities, visual disturbances, or metabolic issues.

• Diagnosis: Involves hormonal assays, MRI imaging of the hypothalamic-pituitary region, and dynamic testing (e.g., stimulation or suppression tests).

• Treatment: Usually hormone replacement therapy, surgical removal of tumors, or radiotherapy; management depends on the specific disease entity.

• Key Relationships: Hypothalamic and pituitary diseases often coexist with or mimic other endocrine disorders, requiring careful differential diagnosis.

💡 Key Takeaway

Disorders of the hypothalamus and pituitary gland can cause complex hormonal imbalances with diverse clinical presentations; accurate diagnosis and targeted treatment are essential for optimal management.

📊 Synthesis Tables

⚠️ Common Pitfalls & Confusions

1. Misinterpreting TSH levels: Elevated TSH indicates primary hypothyroidism; low TSH suggests secondary (pituitary/hypothalamic) causes.
2. Confusing T3/T4 levels: T3 is more potent; T4 is more abundant. Both should be interpreted together.
3. Overlooking feedback mechanisms: High T3/T4 suppress TSH; low T3/T4 stimulate TSH secretion.
4. Mistaking autoimmune markers: Anti-TPO antibodies are specific for Hashimoto's; anti-thyroglobulin less specific.
5. Ignoring iodine deficiency: Can cause hypothyroidism and goiter, mimicking autoimmune disease.
6. Confusing hyperthyroidism treatments: RAI causes destruction, potentially leading to hypothyroidism; surgery is definitive.
7. Misdiagnosing thyroiditis: Transient hyperthyroidism with low TSH and high T4, often followed by hypothyroidism.
8. Assuming all goiters are malignant: Most are benign; ultrasound and antibody tests help differentiate.
9. Incorrectly interpreting ultrasound: Heterogeneous gland suggests autoimmune thyroiditis; nodules require further assessment.
10. Overlooking medication effects: Drugs like amiodarone can alter thyroid function tests.

✅ Exam Checklist

• Understand the regulation and feedback mechanisms of TSH and thyroid hormones.
• Recognize the clinical significance of TSH, T3, and T4 levels in thyroid disorders.
• Identify autoimmune markers (anti-TPO, anti-thyroglobulin) and their diagnostic value.
• Describe the steps of thyroid hormone synthesis, including iodide trapping, organification, and coupling.
• Differentiate between primary and secondary thyroid disorders based on hormone and TSH levels.
• Know the main treatment options for hyperthyroidism and their mechanisms.
• Interpret thyroid ultrasound findings in autoimmune thyroiditis and nodular disease.
• Recognize the key features and markers of autoimmune thyroiditis.
• Understand the pathophysiology and management of thyroid storm.
• Be familiar with the principles of insulin therapy and diabetic complication screening.
• Recall the hormonal regulation and clinical features of adrenal gland disorders.
• Identify pituitary and hypothalamic diseases based on hormonal patterns and clinical presentation.